TY  - GEN
AU  - Iglesias-Caballero, Maria
AU  - Mas-Lloret, Vicente
AU  - Campoy, Albert
AU  - Calvo, Cristina
AU  - García, María Luz
AU  - Alcolea, Sonia
AU  - Moreno-Parrado, Laura
AU  - Reina, Jordi
AU  - Navascués, Ana
AU  - Antón, Andrés
AU  - Davina-Nunez, Carlos
AU  - Perez-Castro, Sonia
AU  - Costa, José
AU  - Fernández-González, Ana
AU  - Lepe, José Antonio
AU  - Gaona, Cristina
AU  - Pérez, Zulema
AU  - García-Martínez de Artola, Diego
AU  - Vázquez-Morón, Sonia
AU  - Camarero-Serrano, Sara
AU  - Cano, Olga
AU  - Pozo Sanchez, Francisco
AU  - Casas Flecha, Inmaculada
PY  - 2026
DO  - 10.1093/infdis/jiaf530
UR  - https://hdl.handle.net/20.500.12105/27698
AB  - Respiratory Syncytial Virus (RSV) is a leading cause of respiratory infections in infants and older adults. In Spain, surveillance is supported by the SiVIRA system and the RELECOV genomic sequencing network. The 2023-2024 season marked the first...
LA  - eng
PB  - Oxford University Press
KW  - RELECOV
KW  - Multicentre study
KW  - RSV
KW  - Genomic and antigenic surveillance
KW  - Nirsevimab
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Viral
KW  - Antigens, Viral
KW  - Antiviral Agents
KW  - Female
KW  - Genetic Variation
KW  - Genome, Viral
KW  - Humans
KW  - Infant
KW  - Phylogeny
KW  - Respiratory Syncytial Virus Infections
KW  - Respiratory Syncytial Virus, Human
KW  - Seasons
KW  - Spain
KW  - Viral Fusion Proteins
TI  - Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.
TY  - research article
ER  -